| |
| | [No title] |
 | | Coronary revascularization plays an important role in the treatment of clinically severe coronary artery disease. |
 | | Patients were ineligible for the trial if they had, for example, insufficient angina or ischemia, required emergency revascularization, left main stenosis of 50 percent or greater, a noncardiac illness expected to result in limited survival, primary coronary spasm, or a poor quality angiogram. |
 | | Finally, all patients who have evidence of coronary artery disease, with or without a prior PTCA or CABG, should receive an aggressive approach to medical management of known risk factors for coronary artery disease, including smoking cessation for smokers, appropriate control of elevated blood pressure or serum cholesterol, and optimal control of diabetes. |
| www.nhlbi.nih.gov /new/press/clinalrt.txt (1236 words) |
|